Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find ...

TAE Life Sciences is a trailblazer in the development of accelerator-based neutron systems and boron-10 drug compounds for Boron Neutron Capture Therapy (BNCT). The company's mission is to create a ...

A study on fasting and the ketogenic diet uncovers a newfound weakness in pancreatic tumors, making them more susceptible to ...

The NIH is one of 13 operating divisions in the U.S. Department of Health and Human Services, now run by Robert F. Kennedy Jr ...

Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...

I commend the NIH for Tuesday’s announcement that it will begin leaning into human- rather than animal-based research.

New research shows a drug candidate's potential to combat liver disease and atherosclerosis effectively in nonhuman primates.

Organoids, miniaturized, stem cell-derived versions of human organs, are revolutionizing biomedical research by offering human-specific models for disease study and drug testing. While they have ...

In April, both the National Institutes of Health and the US Food and Drug Administration announced plans to phase out the use ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Numerous studies have suggested the cultivation of cells derived from intestinal organoids as two-dimensional (2D) monolayers ...

The National Institutes of Health (NIH) is following in the FDA’s footsteps—away from animal testing.  | The National ...